Glaukos Beheer
Beheer criteriumcontroles 3/4
De CEO Glaukos is Tom Burns, benoemd in Apr2002, heeft een ambtstermijn van 22.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.65M, bestaande uit 8.8% salaris en 91.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 2.69% van de aandelen van het bedrijf, ter waarde $ 194.46M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 10.3 jaar.
Belangrijke informatie
Tom Burns
Algemeen directeur
US$8.7m
Totale compensatie
| Percentage CEO-salaris | 8.8% |
| Dienstverband CEO | 22.6yrs |
| Eigendom CEO | 2.7% |
| Management gemiddelde ambtstermijn | 2.6yrs |
| Gemiddelde ambtstermijn bestuur | 10.3yrs |
Recente managementupdates
Recent updates
Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?
Sep 18
Glaukos Corporation: Ripe For Some Consolidation
Sep 11Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 28Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 07Glaukos Corporation's (NYSE:GKOS) Popularity With Investors Is Clear
Jul 18Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt
Jun 11Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun
May 30Here's Why Glaukos Corporation's (NYSE:GKOS) CEO Compensation Is The Least Of Shareholders' Concerns
May 24Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Apr 22Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing
Apr 04Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price
Feb 21Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos Corporation's (NYSE:GKOS) 27% Jump Shows Its Popularity With Investors
Dec 20Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Nov 03Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Risks To Shareholder Returns Are Elevated At These Prices For Glaukos Corporation (NYSE:GKOS)
Apr 19Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through
Feb 14Glaukos sees positive data from mid-stage trial of dry eye treatment
Jan 10Glaukos: Show Me The Money
Nov 10Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Glaukos pays $10M upfront to license iVeena's eye disorder therapy IVMED-80
Aug 24Glaukos: Gross Margins Compressing Despite FY22 Guidance Revision
Aug 04Glaukos gains as Stifel upgrades to Buy citing 2022 sales upside
Jul 12Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$159m |
| Mar 31 2024 | n/a | n/a | -US$141m |
| Dec 31 2023 | US$9m | US$765k | -US$135m |
| Sep 30 2023 | n/a | n/a | -US$129m |
| Jun 30 2023 | n/a | n/a | -US$126m |
| Mar 31 2023 | n/a | n/a | -US$139m |
| Dec 31 2022 | US$6m | US$730k | -US$99m |
| Sep 30 2022 | n/a | n/a | -US$90m |
| Jun 30 2022 | n/a | n/a | -US$56m |
| Mar 31 2022 | n/a | n/a | -US$28m |
| Dec 31 2021 | US$7m | US$702k | -US$50m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$83m |
| Dec 31 2020 | US$6m | US$608k | -US$120m |
| Sep 30 2020 | n/a | n/a | -US$73m |
| Jun 30 2020 | n/a | n/a | -US$71m |
| Mar 31 2020 | n/a | n/a | -US$37m |
| Dec 31 2019 | US$6m | US$644k | US$15m |
| Sep 30 2019 | n/a | n/a | -US$19m |
| Jun 30 2019 | n/a | n/a | -US$12m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | US$5m | US$625k | -US$13m |
| Sep 30 2018 | n/a | n/a | -US$14m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$5m | US$600k | -US$92k |
Compensatie versus markt: De totale vergoeding ($USD 8.65M ) Tom } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.06M ).
Compensatie versus inkomsten: De vergoeding van Tom is gestegen terwijl het bedrijf verliesgevend is.
CEO
Tom Burns (63 yo)
22.6yrs
Tenure
US$8,654,684
Compensatie
Mr. Thomas William Burns, also known as Tom, has been the Chief Executive Officer at Glaukos Corporation since April 1, 2022 and serves as its Chairman of the Board since December 31, 2021. He had Presiden...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 22.6yrs | US$8.65m | 2.69% $ 194.5m | |
| President & COO | 2.6yrs | US$4.18m | 0.047% $ 3.4m | |
| Senior VP & CFO | 2.6yrs | US$2.36m | 0.052% $ 3.8m | |
| Chief Development Officer | 4.1yrs | US$2.57m | 0.048% $ 3.5m | |
| Co-Founder | no data | geen gegevens | geen gegevens | |
| Vice President of Investor Relations & Corporate Affairs | no data | geen gegevens | geen gegevens | |
| VP of Compliance & Deputy General Counsel | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Human Resources | 9.5yrs | geen gegevens | geen gegevens | |
| Executive Vice President of Global Commercial Operations | 2.6yrs | US$198.66k | 0% $ 0 | |
| Senior Vice President of Corporate Strategy & Business Development | 6.6yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Governance | 1.3yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Global Quality & Medical Safety | less than a year | geen gegevens | geen gegevens |
2.6yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van GKOS wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 22.7yrs | US$8.65m | 2.69% $ 194.5m | |
| Independent Director | 4.7yrs | US$259.00k | 0.054% $ 3.9m | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 10.3yrs | US$259.00k | 0.075% $ 5.4m | |
| Lead Independent Director | 10.3yrs | US$319.38k | 0.055% $ 4.0m | |
| Independent Director | 10.3yrs | US$262.13k | 0.066% $ 4.8m | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 10.3yrs | US$273.39k | 0.051% $ 3.7m | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens |
10.3yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van GKOS zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.3 jaar).